Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
- PMID: 28347659
- DOI: 10.1016/j.urolonc.2017.02.010
Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
Abstract
Objectives: To investigate the effect of variant histology (VH) on survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma (UTUC) and the effect of adjuvant chemotherapy on the survival of patients with UTUC with VH.
Materials and methods: A total of 452 patients who underwent radical nephroureterectomy for UTUC without neoadjuvant chemotherapy in our institution between 1991 and 2012 were retrospectively analyzed. We performed a comparative analysis between pure UTUC and UTUC with VH groups. The Kaplan-Meier method was used to calculate survival estimates for cancer-specific survival (CSS) and overall survival (OS), and log-rank test was used to conduct comparisons between the groups. Univariate and multivariate Cox-proportional hazard regression analyses were performed to evaluate significant variables associated with CSS and OS.
Results: UTUC with VH was present in 41 (9.1%) patients. UTUC with VH showed aggressive clinicopathological features in comparison with pure UTUC. The Kaplan-Meier curves showed significantly decreased 5-year CSS and OS (both, P<0.001) in UTUC with VH group. Multivariate analysis revealed that VH was an independent predictor of CSS (P<0.001) and OS (P<0.002). The Kaplan-Meier curves also showed significantly decreased 5-year CSS and OS in UTUC with the VH group compared to the pure UTUC group in patients who received adjuvant chemotherapy.
Conclusions: We found that UTUC with VH harbored aggressive biologic features, and VH was an independent prognostic factor for CSS and OS on both univariate and multivariate analyses. In addition, UTUC with VH group had poorer survival outcomes than pure UTUC group in patients who received adjuvant chemotherapy. Consequently, adjuvant treatment modalities other than adjuvant chemotherapy should be considered in this group.
Keywords: Radical nephroureterectomy; Upper urinary tract urothelial carcinoma; Variant histology.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.Clin Genitourin Cancer. 2019 Jun;17(3):e394-e407. doi: 10.1016/j.clgc.2018.11.015. Epub 2019 Jan 11. Clin Genitourin Cancer. 2019. PMID: 30782419
-
Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.Urol Oncol. 2015 May;33(5):204.e9-16. doi: 10.1016/j.urolonc.2015.02.010. Epub 2015 Mar 20. Urol Oncol. 2015. PMID: 25800374
-
Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.World J Urol. 2017 Oct;35(10):1569-1575. doi: 10.1007/s00345-017-2032-6. Epub 2017 Apr 10. World J Urol. 2017. PMID: 28397000
-
Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.Int J Clin Oncol. 2020 Jun;25(6):1037-1054. doi: 10.1007/s10147-020-01650-9. Epub 2020 Mar 23. Int J Clin Oncol. 2020. PMID: 32206939
-
Adjuvant Chemotherapy after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma with Variant Histology: A Systematic Review and Meta-Analysis of Survival Outcomes.Urol Int. 2024;108(4):339-348. doi: 10.1159/000538545. Epub 2024 Mar 26. Urol Int. 2024. PMID: 38531343
Cited by
-
Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy.World J Urol. 2024 Apr 9;42(1):225. doi: 10.1007/s00345-024-04878-6. World J Urol. 2024. PMID: 38592495 Free PMC article.
-
Impact of Pathology Review in Adverse Histological Characteristics and pT Stages of Upper Tract Urothelial Cancer in a Multicenter Study.Front Oncol. 2021 Nov 25;11:757359. doi: 10.3389/fonc.2021.757359. eCollection 2021. Front Oncol. 2021. PMID: 34900706 Free PMC article.
-
Sarcomatoid Variant of Urothelial Carcinoma of the Renal Pelvis with Inferior Vena Cava Tumour Thrombus: A Case Report and Literature Review.Case Rep Pathol. 2018 Jan 17;2018:1837510. doi: 10.1155/2018/1837510. eCollection 2018. Case Rep Pathol. 2018. PMID: 29581908 Free PMC article.
-
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis.Front Oncol. 2022 Apr 22;12:843715. doi: 10.3389/fonc.2022.843715. eCollection 2022. Front Oncol. 2022. PMID: 35530335 Free PMC article.
-
Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.Curr Oncol Rep. 2019 Feb 26;21(3):23. doi: 10.1007/s11912-019-0772-8. Curr Oncol Rep. 2019. PMID: 30806832 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources